ACRIN-6698

The American College of Radiology Imaging Network (ACRIN) trial 6698 was a multi-center study to evaluate the effectiveness of quantitative diffusion weighted imaging (DWI) for assessing breast cancer response to neoadjuvant chemotherapy (NAC). ACRIN 6698 was performed as a sub-study of the ongoing I-SPY 2 TRIAL (Investigation of Serial studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2), an adaptive, multi-agent phase II trial designed to quickly identify new agents for breast cancer. Please see the ACRIN 6698/I-SPY2 Breast DWI wiki page to learn more about the images and to obtain any supporting metadata for this collection.